<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2002-752</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-889</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТИВНОСТЬ И ПЕРЕНОСИМОСТЬ НИМЕСИЛАРАСТВОРИМОЙ ФОРМЫ НИМЕСУЛИДА - ПРИ РЕВМАТОИДНОМ АРТРИТЕ (ПРЕДВАРИТЕЛЬНЫЕ РЕЗУЛЬТАТЫ)</article-title><trans-title-group xml:lang="en"><trans-title>EFFICACY ANDTOLERABILITY OF NIMESIL-SOLUBLE FORM OF NIMESULID IN RHEUMATOID ARTHRITIS(PRELIMINARY RESULTS)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балабанова</surname><given-names>Римма Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Balabanova</surname><given-names>R. M.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>15</day><month>02</month><year>2002</year></pub-date><volume>40</volume><issue>1</issue><issue-title>№1 (2002)</issue-title><fpage>60</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Балабанова Р.М., 2002</copyright-statement><copyright-year>2002</copyright-year><copyright-holder xml:lang="ru">Балабанова Р.М.</copyright-holder><copyright-holder xml:lang="en">Balabanova R.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/889">https://rsp.mediar-press.net/rsp/article/view/889</self-uri><abstract><p>Изучение эффективности и переносимости растворимой формы нимесулида- нимесила 200 мг/сутки у 30 больных ревматоидным артритом в 8 недельном контролируемом исследовании показало, что ннмесил обладает выраженным аналгетическим и противовоспалительным действием, о чем свидетельствует снижение выраженности боли (ВАШ, мм), числа болезненных и воспаленных суставов, В 77% случаев эффект оценен как хороший. Препарат отменен у 3 больных из-за развития побочных эффектов - у 2-со стороны желудочно- кишечного тракта, у 1- отек лица.</p></abstract><trans-abstract xml:lang="en"><p>Efficacy and tolerability of soluble nimesulid (nimesil) 200 mg/day was assessed in 30 patients with rheumatoid arthritis during an 8-weeks controlled study. Nimesil showed significant analgetic and antiinflammatory effects confirmed by decrease of pain, swollen and painful joint count. Effect was considered as good in 77% of cases. The drug was withdrawn in 3 patients because of side effects (gastrointestinal in 2 and face oedema in I)</p></trans-abstract><kwd-group xml:lang="ru"><kwd>РА</kwd><kwd>нимесил (нимесулид)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>RA</kwd><kwd>nimesil (nimesulid)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Bennett A. Clinical importance of the multifactorial actions of nimesulide. Drugs today, 2001, 37. suppl B, 9-14.&lt;/p&gt;&lt;p&gt;Fammaey J. P. Vandekerckhovc K. et. al. A large, open- lable triel of nimesulide in patients with osteoarticular conditions treated in a general practice setting. Cuit. Ther. Res., 1998. 59, 467-82. "&lt;/p&gt;&lt;p&gt;Huskisson E.C. Nimesulide, a balanced drugs for the treatment of osteoarthritis. Clin. Exper. Rheum. 2001, 19. I, 21-25.&lt;/p&gt;&lt;p&gt;Pochobradsky M. G., Mele G., Beretta A. et al. Post marketting survey of nimesulide in the short - term treatment of osteoarthritis. Drugs Expte Clin Res., 1991,17,197-204.&lt;/p&gt;&lt;p&gt;Rainsford K.D. Nimesulide: overview of propeties and applications. Drugs today, 2001, 37, suppl B, 3-7.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Bennett A. Clinical importance of the multifactorial actions of nimesulide. Drugs today, 2001, 37. suppl B, 9-14.&lt;/p&gt;&lt;p&gt;Fammaey J. P. Vandekerckhovc K. et. al. A large, open- lable triel of nimesulide in patients with osteoarticular conditions treated in a general practice setting. Cuit. Ther. Res., 1998. 59, 467-82. "&lt;/p&gt;&lt;p&gt;Huskisson E.C. Nimesulide, a balanced drugs for the treatment of osteoarthritis. Clin. Exper. Rheum. 2001, 19. I, 21-25.&lt;/p&gt;&lt;p&gt;Pochobradsky M. G., Mele G., Beretta A. et al. Post marketting survey of nimesulide in the short - term treatment of osteoarthritis. Drugs Expte Clin Res., 1991,17,197-204.&lt;/p&gt;&lt;p&gt;Rainsford K.D. Nimesulide: overview of propeties and applications. Drugs today, 2001, 37, suppl B, 3-7.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
